• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Class action lawsuit against NuVasive proves a huge draw

Class action lawsuit against NuVasive proves a huge draw

September 5, 2013 By Arezu Sarvestani

Class action lawsuit against NuVasive proves a huge draw

California spinal devices maker NuVasive Inc. (NSDQ:NUVA) has recently gotten very popular with law firms, which began piling onto a class action lawsuit following the revelation that the company is under investigation by the Health & Human Services Dept.’s Office of the Inspector General.

The firm of Glancy Binkow & Goldberg, representing NuVasive shareholders, filed a class action lawsuit against the company in the U.S. District Court for the Southern District of California, which drew a lot of attention from fellow firms.

The lawsuit accuses NuVasive of making false statements about its business operations and submitting fake claims for reimbursement from Medicare and Medicaid, falsely inflating NUVA shares, which dropped hard after the company revealed the OIG probe.

NuVasive in July revealed in a regulatory filing that the OIG issued a subpoena "in connection with an investigation into possible false or otherwise improper claims submitted to Medicare and Medicaid," for documents from January 2007 through April of this year.

NuVasive said at the time that it was "working with the OIG to understand the scope of the subpoena," but the company didn’t expect to have more information on the probe for a few months.

Several additional law firms have released statement about the lawsuit, either joining in or soliciting potential plaintiffs. The Boulder, Colo.-based Shuman Law Firm said that it’s "investigating potential claims" against NuVasive and certain of its officers, and Berkeley, Calif.’s Hagens Berman Sobol Shapiro warned any potential claimants that they have until Oct. 28, 2013, to move to be named lead plaintiff in the Southern California lawsuit.

NUVA shares have dropped nearly 12% since closing at $26.99 on July24, 2013. Shares closed at $23.79 last night and were up 0.2% to $23.83 as of about 3:30 p.m.

Filed Under: Legal News, Medicare, News Well, Wall Street Beat Tagged With: Dept. of Health & Human Services (HHS), Medicare Fraud, Nuvasive

More recent news

  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy